149 related articles for article (PubMed ID: 34820689)
21. Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.
Park HJ; Jang KM; Kang TW; Song KD; Kim SH; Kim YK; Cha DI; Kim J; Goo J
Eur Radiol; 2016 Sep; 26(9):3102-11. PubMed ID: 26634931
[TBL] [Abstract][Full Text] [Related]
22. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
23. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.
Kinoshita M; Kanazawa A; Takemura S; Tanaka S; Kodai S; Shinkawa H; Shimizu S; Murata A; Nishio K; Hamano G; Ito T; Tsukamoto T; Kubo S
Asian J Endosc Surg; 2020 Jan; 13(1):46-58. PubMed ID: 30924307
[TBL] [Abstract][Full Text] [Related]
24. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.
Yuan MX; Li R; Zhang XH; Tang CL; Guo YL; Guo DY; Luo MK
Ultraschall Med; 2016 Dec; 37(6):609-618. PubMed ID: 25919414
[No Abstract] [Full Text] [Related]
25. The value of Gd-BOPTA- enhanced MRIs and DWI in the diagnosis of intrahepatic mass-forming cholangiocarcinoma.
Xu CC; Tang YF; Ruan XZ; Huang QL; Sun L; Li J
Neoplasma; 2017; 64(6):945-953. PubMed ID: 28895422
[TBL] [Abstract][Full Text] [Related]
26. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
Kang Y; Lee JM; Kim SH; Han JK; Choi BI
Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
[TBL] [Abstract][Full Text] [Related]
27. Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
Fujita N; Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Moirta K; Shirabe K; Aishima S; Wang H; Oda Y; Honda H
Eur Radiol; 2017 Feb; 27(2):498-506. PubMed ID: 27165138
[TBL] [Abstract][Full Text] [Related]
28. Apparent diffusion coefficient value of mass-forming intrahepatic cholangiocarcinoma: a potential imaging biomarker for prediction of lymph node metastasis.
Zhou Y; Zhou G; Gao X; Xu C; Wang X; Xu P
Abdom Radiol (NY); 2020 Oct; 45(10):3109-3118. PubMed ID: 32107582
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
30. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
31. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
[TBL] [Abstract][Full Text] [Related]
32. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Wang X; Xu P
Eur Radiol; 2021 Sep; 31(9):6846-6855. PubMed ID: 33638019
[TBL] [Abstract][Full Text] [Related]
33. Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics.
Nanashima A; Abo T; Murakami G; Matsumoto A; Tou K; Takeshita H; Kunizaki M; Hidaka S; Sakamoto I; Hayashi H; Fukuda T; Kudo T; Nagayasu T
Abdom Imaging; 2013 Aug; 38(4):785-92. PubMed ID: 23232581
[TBL] [Abstract][Full Text] [Related]
34. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
[TBL] [Abstract][Full Text] [Related]
35. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
[TBL] [Abstract][Full Text] [Related]
36. Intrahepatic Mass-Forming Cholangiocarcinoma: Relationship Between Computed Tomography Characteristics and Histological Subtypes.
Nam JG; Lee JM; Joo I; Ahn SJ; Park JY; Lee KB; Han JK
J Comput Assist Tomogr; 2018; 42(3):340-349. PubMed ID: 29189405
[TBL] [Abstract][Full Text] [Related]
37. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
38. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
Seo N; Kim DY; Choi JY
AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of small intrahepatic mass-forming cholangiocarcinoma from small liver abscess by dual source dual-energy CT quantitative parameters.
Kim JE; Kim HO; Bae K; Cho JM; Choi HC; Choi DS
Eur J Radiol; 2017 Jul; 92():145-152. PubMed ID: 28624012
[TBL] [Abstract][Full Text] [Related]
40. Multi-detector spiral CT diagnosis of common bile duct ampullary carcinoma.
Zhao DZ; Guo Y; Sun YP; Liu HM; Zhang Z; Ma QL; Wang YS; Chen CL
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3549-3553. PubMed ID: 28925490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
